Xu, Li <br/><br/>
Long-term therapy with sorafenib is associated with pancreatic atrophy.  [electronic resource] 

 -  The Journal of surgical research  Dec 2015 
 - 314-21 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1095-8673 
<br/><br/><label>Standard No.: </label>10.1016/j.jss.2015.04.035  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Atrophy--chemically induced<br/>Carcinoma, Hepatocellular--drug therapy<br/>China--epidemiology<br/>Cohort Studies<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Niacinamide--administration & dosage<br/>Pancreas--pathology<br/>Pancreatic Diseases--chemically induced<br/>Phenylurea Compounds--administration & dosage<br/>Sorafenib<br/>Treatment Outcome